492 related articles for article (PubMed ID: 15903242)
1. Effects of elevated pCO2 and osmolality on growth of CHO cells and production of antibody-fusion protein B1: a case study.
Zhu MM; Goyal A; Rank DL; Gupta SK; Vanden Boom T; Lee SS
Biotechnol Prog; 2005; 21(1):70-7. PubMed ID: 15903242
[TBL] [Abstract][Full Text] [Related]
2. Selected amino acids protect hybridoma and CHO cells from elevated carbon dioxide and osmolality.
deZengotita VM; Abston LR; Schmelzer AE; Shaw S; Miller WM
Biotechnol Bioeng; 2002 Jun; 78(7):741-52. PubMed ID: 12001166
[TBL] [Abstract][Full Text] [Related]
3. Hyperosmotic stress and elevated pCO2 alter monoclonal antibody charge distribution and monosaccharide content.
Schmelzer AE; Miller WM
Biotechnol Prog; 2002; 18(2):346-53. PubMed ID: 11934306
[TBL] [Abstract][Full Text] [Related]
4. Dependence on glucose limitation of the pCO2 influences on CHO cell growth, metabolism and IgG production.
Takuma S; Hirashima C; Piret JM
Biotechnol Bioeng; 2007 Aug; 97(6):1479-88. PubMed ID: 17318909
[TBL] [Abstract][Full Text] [Related]
5. Identifying inhibitory threshold values of repressing metabolites in CHO cell culture using multivariate analysis methods.
Xing Z; Li Z; Chow V; Lee SS
Biotechnol Prog; 2008; 24(3):675-83. PubMed ID: 18422365
[TBL] [Abstract][Full Text] [Related]
6. A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
Wang IK; Hsieh SY; Chang KM; Wang YC; Chu A; Shaw SY; Ou JJ; Ho L
J Biotechnol; 2006 Feb; 121(3):418-28. PubMed ID: 16162365
[TBL] [Abstract][Full Text] [Related]
7. A systematic approach for scale-down model development and characterization of commercial cell culture processes.
Li F; Hashimura Y; Pendleton R; Harms J; Collins E; Lee B
Biotechnol Prog; 2006; 22(3):696-703. PubMed ID: 16739951
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of CHO-derived recombinant tPA produced under elevated pCO2.
Kimura R; Miller WM
Biotechnol Prog; 1997; 13(3):311-7. PubMed ID: 9190082
[TBL] [Abstract][Full Text] [Related]
9. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures.
Cherlet M; Marc A
Biotechnol Prog; 1998; 14(4):626-38. PubMed ID: 9694686
[TBL] [Abstract][Full Text] [Related]
10. Effects of elevated pCO(2) and/or osmolality on the growth and recombinant tPA production of CHO cells.
Kimura R; Miller WM
Biotechnol Bioeng; 1996 Oct; 52(1):152-60. PubMed ID: 18629861
[TBL] [Abstract][Full Text] [Related]
11. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
12. Decreasing lactate level and increasing antibody production in Chinese Hamster Ovary cells (CHO) by reducing the expression of lactate dehydrogenase and pyruvate dehydrogenase kinases.
Zhou M; Crawford Y; Ng D; Tung J; Pynn AF; Meier A; Yuk IH; Vijayasankaran N; Leach K; Joly J; Snedecor B; Shen A
J Biotechnol; 2011 Apr; 153(1-2):27-34. PubMed ID: 21392546
[TBL] [Abstract][Full Text] [Related]
13. Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium.
Link T; Bäckström M; Graham R; Essers R; Zörner K; Gätgens J; Burchell J; Taylor-Papadimitriou J; Hansson GC; Noll T
J Biotechnol; 2004 May; 110(1):51-62. PubMed ID: 15099905
[TBL] [Abstract][Full Text] [Related]
14. Enhanced interferon-beta production by CHO cells through elevated osmolality and reduced culture temperature.
Han YK; Koo TY; Lee GM
Biotechnol Prog; 2009; 25(5):1440-7. PubMed ID: 19572287
[TBL] [Abstract][Full Text] [Related]
15. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
[TBL] [Abstract][Full Text] [Related]
16. Scale-up analysis for a CHO cell culture process in large-scale bioreactors.
Xing Z; Kenty BM; Li ZJ; Lee SS
Biotechnol Bioeng; 2009 Jul; 103(4):733-46. PubMed ID: 19280669
[TBL] [Abstract][Full Text] [Related]
17. Effects of culture conditions on N-glycolylneuraminic acid (Neu5Gc) content of a recombinant fusion protein produced in CHO cells.
Borys MC; Dalal NG; Abu-Absi NR; Khattak SF; Jing Y; Xing Z; Li ZJ
Biotechnol Bioeng; 2010 Apr; 105(6):1048-57. PubMed ID: 20039310
[TBL] [Abstract][Full Text] [Related]
18. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
[TBL] [Abstract][Full Text] [Related]
19. Temperature reduction in cultures of hGM-CSF-expressing CHO cells: effect on productivity and product quality.
Bollati-Fogolín M; Forno G; Nimtz M; Conradt HS; Etcheverrigaray M; Kratje R
Biotechnol Prog; 2005; 21(1):17-21. PubMed ID: 15903236
[TBL] [Abstract][Full Text] [Related]
20. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1033-44. PubMed ID: 16736530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
